Skip to main content
Top
Published in: Breast Cancer Research 2/2008

01-05-2008 | Poster presentation

Actions of IGF-I are differentially regulated by fatty acids in normal and breast cancer epithelial cells

Authors: CM Perks, AA Morrison, L Zeng, C Jarrett, J Shield, ZE Winters, JMP Holly

Published in: Breast Cancer Research | Special Issue 2/2008

Login to get access

Excerpt

Obesity will soon be the leading preventable risk factor for many cancers. The insulin-like growth factors (IGFs) have been strongly implicated as important risk factors for many epithelial cancers, including breast cancer, and for mediating the link between nutrition and these cancers. Obesity-related increases in circulating fatty acids cause insulin resistance with consequent morbidity but, despite the considerable overlap between insulin and IGFs, there have been no studies of the effects of fatty acids on IGF activity. …
Metadata
Title
Actions of IGF-I are differentially regulated by fatty acids in normal and breast cancer epithelial cells
Authors
CM Perks
AA Morrison
L Zeng
C Jarrett
J Shield
ZE Winters
JMP Holly
Publication date
01-05-2008
Publisher
BioMed Central
Published in
Breast Cancer Research / Issue Special Issue 2/2008
Electronic ISSN: 1465-542X
DOI
https://doi.org/10.1186/bcr1923

Other articles of this Special Issue 2/2008

Breast Cancer Research 2/2008 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine